Hospital-acquired pneumonia: Difference between revisions
Line 22: | Line 22: | ||
==Diagnosis== | ==Diagnosis== | ||
==Differential diagnosis== | ==Differential diagnosis== |
Revision as of 20:19, 5 September 2012
Hospital-acquired pneumonia Microchapters |
Differentiating Hospital-Acquired Pneumonia from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Hospital-acquired pneumonia On the Web |
American Roentgen Ray Society Images of Hospital-acquired pneumonia |
Directions to Hospitals Treating Hospital-acquired pneumonia |
Risk calculators and risk factors for Hospital-acquired pneumonia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Hospital-acquired pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Treatment
Medical Therapy
Prevention
Diagnosis
Differential diagnosis
Treatment
Usually initial therapy is empirical.[1] If sufficient reason to suspect influenza one might consider amantadine or rimantadine. In case of legionellosis erythromicin or fluoroquinolone.[2]
A third generation cephalosporin (ceftazidime) + carbapenems (imipenem) + beta lactam & beta lactamase inhibitors (piperacillin/tazobactum)